Sergey I Kutsev
Overview
Explore the profile of Sergey I Kutsev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostyuk S, Malinovskaya E, Umriukhin P, Proskurnina E, Ershova E, Kameneva L, et al.
Front Biosci (Landmark Ed)
. 2024 Dec;
29(12):408.
PMID: 39735985
Background: There is a growing interest in exploring the biological characteristics of nanoparticles and exploring their potential applications. However, there is still a lack of research into the potential genotoxicity...
2.
Kostyuk S, Malinovskaya E, Umriukhin P, Mikheeva E, Ershova E, Savinova E, et al.
Front Biosci (Landmark Ed)
. 2024 Oct;
29(10):352.
PMID: 39473423
Background: The new synthesized water-soluble derivatives of C fullerenes are of a great interest to researchers since they can potentially be promising materials for drug delivery, bioimaging, biosonding, and tissue...
3.
Bobreshova A, Ionova S, Kadyshev V, Sukhanova N, Viakhireva I, Filatova A, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457042
Hermansky-Pudlak syndrome (HPS) is a rare disease inherited in the autosomal recessive mode, including 11 clinical genetic subtypes. They are associated with impaired function of the BLOC protein complex (Biogenesis...
4.
Ionova S, Murtazina A, Marakhonov A, Shchagina O, Ryadninskaya N, Tebieva I, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273681
Myotonic dystrophy type 1 (DM1) is a multisystem disorder with progressive myopathy and myotonia. The clinical study was conducted in the Republic of North Ossetia-Alania (RNOA), and in it 39...
5.
Merkuryeva E, Markova T, Kenis V, Agranovich O, Dan I, Kotalevskaya Y, et al.
Genes (Basel)
. 2024 Jun;
15(6).
PMID: 38927610
Pathogenic variants in the gene lead to a spectrum of rare autosomal recessive phenotypes, including osteogenesis imperfecta (OI) Type XI, Bruck syndrome Type I (BS I), and the congenital arthrogryposis-like...
6.
Efimova I, Zinchenko R, Marakhonov A, Balinova N, Mikhalchuk K, Shchagina O, et al.
Pediatr Neurol
. 2024 May;
156:147-154.
PMID: 38781723
Background: This study presents the findings of a newborn screening (NBS) pilot project for 5q-spinal muscular atrophy (5q-SMA) in multiple regions across Russia for during the year 2022. The aim...
7.
Tebieva I, Mishakova P, Gabisova Y, Khokhova A, Kaloeva T, Marakhonov A, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38731816
This study, conducted in the Republic of North Ossetia-Alania (RNOA), aimed to explore the genetic landscape of hyperphenylalaninemia (HPA) and phenylketonuria (PKU) in the Ossetian population using data from newborn...
8.
Marakhonov A, Efimova I, Mukhina A, Zinchenko R, Balinova N, Rodina Y, et al.
J Clin Immunol
. 2024 Apr;
44(4):93.
PMID: 38578360
Newborn screening (NBS) for severe inborn errors of immunity (IEI), affecting T lymphocytes, and implementing measurements of T cell receptor excision circles (TREC) has been shown to be effective in...
9.
Vasilyeva T, Sukhanova N, Khalanskaya O, Marakhonov A, Prokhorov N, Kadyshev V, et al.
Curr Issues Mol Biol
. 2024 Jan;
46(1):96-105.
PMID: 38248310
This study investigates a unique and complex eye phenotype characterized by minimal iris defects, foveal hypoplasia, optic nerve coloboma, and severe posterior segment damage. Through genetic analysis and bioinformatic tools,...
10.
Kalinkin A, Sigin V, Kuznetsova E, Ignatova E, Vinogradov I, Vinogradov M, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139172
Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype, with a poor survival rate compared to others subtypes. For a long time, chemotherapy was the only systemic treatment for...